| Literature DB >> 26956157 |
Abstract
Cariprazine is a new therapeutic agent recently approved for the treatment of both schizophrenia and manic or mixed episodes associated with bipolar disorder, and is under investigation for the treatment of both bipolar depression and major depressive disorder.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26956157 DOI: 10.1017/S1092852916000043
Source DB: PubMed Journal: CNS Spectr ISSN: 1092-8529 Impact factor: 3.790